Companies: 10,795·Total market cap: $144.5T
Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTXNASDAQHealthcare● Active
$1.46
$-0.04(-2.67%)
Market Cap$2790260
P/E Ratio—
52W High$9.5
52W Low$1.28
PE RatioMarket CapForecast

Dogwood Therapeutics, Inc. (DWTX) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

dwtx · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Dogwood Therapeutics, Inc. (DWTX) measures how much investors pay for each dollar of the company's trailing earnings. DWTX's current PE ratio of N/A is calculated by dividing its stock price of $1.46 by its TTM earnings per share of -$0.84.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.74
Based on 2 analysts
EPS (TTM)
-$0.84
TTM · diluted EPS
PEG Ratio
-0.14
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Dogwood Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2018 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc.You
DWTX
$3MN/A—-$0.84
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc.
BOLT
$9MN/A—-$17.85
BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc.
BRTX
$3MN/A—-$1.58
Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc.
CLRB
$8MN/A—-$8.35
Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc.
COCP
$10MN/A—-$0.78
Edesa Biotech, Inc.
Edesa Biotech, Inc.
EDSA
$48MN/A—-$1.27
Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc.
ERNA
$2MN/A—-$55.83

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
—$-4.17—
2024-12-31
FY2024
—$-12.02—
2023-12-31
FY2023
—$-7.05—
2022-12-31
FY2022
—$-27.66—
2021-12-31
FY2021
—$-47.90—
2020-12-31
FY2020
—$-52.50—
2019-12-31
FY2019
—$-12.80—
2018-12-31
FY2018
—$-10.93—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Dogwood Therapeutics, Inc. (DWTX) measures how much investors pay for each dollar of the company's trailing earnings. DWTX's current PE ratio of N/A is calculated by dividing its stock price of $1.46 by its TTM earnings per share of -$0.84.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.46 ÷ -$0.84 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

DWTX pe ratio · 6 questions

DWTX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.46 and TTM EPS of -$0.84. Data sourced from Financial Modeling Prep via DWTX's SEC 10-K and 10-Q filings.

DWTX PE ratioWhat is DWTX PE ratioCurrent PE ratio of DWTXDWTX PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Dogwood Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08